Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,880,000 shares, a growth of 5.6% from the April 30th total of 1,780,000 shares. Based on an average daily volume of 475,000 shares, the short-interest […]
Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year […]
Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2024 annual.
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Bausch + Lomb Receives Health Canada Approval for enVista® Envytm* Full Visual Range Intraocular Lens lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.